Potomac, MD, United States of America

Jason B Bock

USPTO Granted Patents = 1 



Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Jason B Bock

Introduction

Jason B Bock, a prominent inventor based in Potomac, MD, has made significant strides in the field of biotechnology. With a single patent to his name, Bock's innovative work revolves around albumin fusion proteins, demonstrating his expertise and commitment to advancing medical science.

Latest Patents

Bock's patent, titled "Albumin Fusion Proteins," encompasses a variety of novel elements related to albumin fusion proteins. The invention includes nucleic acid molecules that encode these proteins, as well as vectors containing these nucleic acids. It further describes host cells transformed with these nucleic acids and methods for producing and utilizing the albumin fusion proteins. The patent also covers pharmaceutical compositions comprising these proteins and outlines methods for treating, preventing, or ameliorating various diseases, disorders, or conditions.

Career Highlights

Jason B Bock has established himself as a valuable member of the scientific community, currently working at Human Genome Sciences, Inc. His research and innovations have potentially opened new pathways in therapeutic applications, showcasing the power of biotechnology in medicine.

Collaborations

Throughout his career, Bock has collaborated with notable colleagues including Craig A Rosen and William A Haseltine. These partnerships reflect a commitment to multidisciplinary teamwork, which is essential for driving innovation and addressing complex medical challenges.

Conclusion

In conclusion, Jason B Bock is an inventor whose work in albumin fusion proteins holds promise for the future of therapeutic development. His contributions not only highlight his individual capabilities but also the collaborative efforts of skilled professionals within the biotechnology sector. As innovations like his continue to emerge, the potential for advancements in treating diseases and improving patient outcomes remains vast.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…